Correlation Between Excelsior Medical and Energenesis Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Excelsior Medical and Energenesis Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Excelsior Medical and Energenesis Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Excelsior Medical Co and Energenesis Biomedical Co, you can compare the effects of market volatilities on Excelsior Medical and Energenesis Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Excelsior Medical with a short position of Energenesis Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Excelsior Medical and Energenesis Biomedical.

Diversification Opportunities for Excelsior Medical and Energenesis Biomedical

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Excelsior and Energenesis is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Excelsior Medical Co and Energenesis Biomedical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Energenesis Biomedical and Excelsior Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Excelsior Medical Co are associated (or correlated) with Energenesis Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Energenesis Biomedical has no effect on the direction of Excelsior Medical i.e., Excelsior Medical and Energenesis Biomedical go up and down completely randomly.

Pair Corralation between Excelsior Medical and Energenesis Biomedical

Assuming the 90 days trading horizon Excelsior Medical is expected to generate 7.54 times less return on investment than Energenesis Biomedical. But when comparing it to its historical volatility, Excelsior Medical Co is 8.02 times less risky than Energenesis Biomedical. It trades about 0.12 of its potential returns per unit of risk. Energenesis Biomedical Co is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  4,930  in Energenesis Biomedical Co on September 15, 2024 and sell it today you would earn a total of  280.00  from holding Energenesis Biomedical Co or generate 5.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Excelsior Medical Co  vs.  Energenesis Biomedical Co

 Performance 
       Timeline  
Excelsior Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Excelsior Medical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Excelsior Medical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Energenesis Biomedical 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Energenesis Biomedical Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Energenesis Biomedical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Excelsior Medical and Energenesis Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Excelsior Medical and Energenesis Biomedical

The main advantage of trading using opposite Excelsior Medical and Energenesis Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Excelsior Medical position performs unexpectedly, Energenesis Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Energenesis Biomedical will offset losses from the drop in Energenesis Biomedical's long position.
The idea behind Excelsior Medical Co and Energenesis Biomedical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum